⌘K
C
Commit Biologics
BiCE™ platform • Cancer
Commit Biologics develops a Bispecific Complement Engaging (BiCE™) platform to target cancer and autoimmune diseases.
BiCE™ platform • Cancer
Commit Biologics develops a Bispecific Complement Engaging (BiCE™) platform to target cancer and autoimmune diseases.